Enhance Pharmacovigilance with DrugCard: AI-Driven Solutions for Drug Safety and Compliance

About drug-card

DrugCard revolutionizes pharmacovigilance with its AI-driven data intelligence, addressing the intricate challenges of drug safety. This platform is indispensable for pharmaceutical companies, contract research organizations (CROs), and regulatory affairs professionals.

Key Features and Benefits

1. Time Efficiency: DrugCard harnesses advanced AI to optimize local literature screening, enabling users to save 50-70% of their time compared to traditional methods. This efficiency allows professionals to redirect their focus toward strategic initiatives, significantly boosting productivity.

2. Global Reach: With the capability to screen over 100 languages and access more than 400 local journals, DrugCard offers a comprehensive global solution. This feature is crucial for organizations in diverse markets, ensuring adherence to local regulations.

3. High Accuracy: Utilizing proprietary OCR technology, DrugCard achieves up to 99% accuracy, even with poorly scanned documents. This reliability is vital for compliance, ensuring that no critical information slips through the cracks during screening.

4. Cost-Effective Growth: The CAPEX-free investment model allows organizations to enhance their pharmacovigilance capabilities without hefty upfront costs, making DrugCard a financially savvy choice.

5. Real-Time Updates: Users receive instant alerts for new drug mentions in local journals, complemented by weekly summary reports that streamline the audit process.

6. User-Friendly Design: DrugCard’s intuitive interface facilitates quick adaptation and integration into existing workflows, minimizing the learning curve and maximizing operational efficiency.

7. Focus on Critical Tasks: By automating routine processes, DrugCard empowers pharmacovigilance professionals to concentrate on essential activities like signal detection and risk assessment, ultimately enhancing drug safety outcomes.

Customer Testimonials

Valentina Eremenko, a PV freelancer, describes DrugCard as a "phenomenal tool that saves time and does local literature screening instead of you." Natalka Ischuk, owner of PV Systems, notes how DrugCard has automated processes, allowing her team to focus on other critical tasks. Vladyslav Vesna, Deputy QPPV at Farmak, highlights the platform's effectiveness in screening local literature from CIS countries.

Conclusion

In a fast-evolving landscape, DrugCard emerges as a transformative solution for pharmacovigilance. Its AI-enabled features, extensive language support, and commitment to accuracy make it an invaluable asset for organizations aiming to enhance drug safety processes. Adopting DrugCard equips companies to navigate pharmacovigilance complexities confidently, ensuring compliance and improving overall efficiency.

List of drug-card features

• AI-enabled Data Intelligence
• Streamlined drug safety routines
• Continuous and regular monitoring
• Traceable and transparent processes
• Accurate and complete data
• Scalable solutions for new markets
• Support for multiple languages
• Coverage of multiple regions
• Cost-effective investments
• Time-saving features
• Integration with local medical journals
• Weekly summary reports
• High accuracy of keyword recognition
• Automation of literature screening
• Enhancements in pharmacovigilance processes